Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoly Toth

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Medicinal Chemistry|November 22, 2023
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable DruggabilityShenghua Gao, Letian Song, Katharina Sylvester, et al.
Nanotoxicology|March 8, 2012
In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface chargesVenugopalan Kasturirangan, Bindu M Nair, Muhammed T S Kariapper, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Synthesis of USC-093 and comparison with its promoiety enantiomer USC-093D against adenovirus in vitro and in a Syrian hamster modelJiayi Yang, Samantha B Riemann, Jinglei Lyu, et al.
Antiviral Research|March 7, 2018
USC-087 protects Syrian hamsters against lethal challenge with human species C adenovirusesKaroly Toth, Jacqueline F Spencer, Baoling Ying, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease InhibitorsShenghua Gao, Letian Song, Tobias Claff, et al.
Journal of Medicinal Chemistry|September 15, 2022
Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low ToxicityShenghua Gao, Katharina Sylvester, Letian Song, et al.
Molecular Pharmaceutics|December 9, 2022
NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety MarginElke Lipka, Aaron M Chadderdon, Cheryl C Harteg, et al.
ACS Infectious Diseases|May 22, 2025
Antiviral Activity of the Acyclic Nucleoside Phosphonate Prodrug LAVR-289 against Poxviruses and African Swine Fever VirusElie Marcheteau, Estelle Mosca, Gaelle Frenois-Veyrat, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Medicinal Chemistry|November 22, 2023
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable DruggabilityShenghua Gao, Letian Song, Katharina Sylvester, et al.
Nanotoxicology|March 8, 2012
In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface chargesVenugopalan Kasturirangan, Bindu M Nair, Muhammed T S Kariapper, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Synthesis of USC-093 and comparison with its promoiety enantiomer USC-093D against adenovirus in vitro and in a Syrian hamster modelJiayi Yang, Samantha B Riemann, Jinglei Lyu, et al.
Antiviral Research|March 7, 2018
USC-087 protects Syrian hamsters against lethal challenge with human species C adenovirusesKaroly Toth, Jacqueline F Spencer, Baoling Ying, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease InhibitorsShenghua Gao, Letian Song, Tobias Claff, et al.
Journal of Medicinal Chemistry|September 15, 2022
Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low ToxicityShenghua Gao, Katharina Sylvester, Letian Song, et al.
Molecular Pharmaceutics|December 9, 2022
NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety MarginElke Lipka, Aaron M Chadderdon, Cheryl C Harteg, et al.
ACS Infectious Diseases|May 22, 2025
Antiviral Activity of the Acyclic Nucleoside Phosphonate Prodrug LAVR-289 against Poxviruses and African Swine Fever VirusElie Marcheteau, Estelle Mosca, Gaelle Frenois-Veyrat, et al.
Pageof 7